A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency

Georgianne L. Arnold, Dwight D. Koeberl, Dietrich Matern, Bruce Barshop, Nancy Braverman, Barbara Burton, Stephen Cederbaum, Annette Fiegenbaum, Cheryl Garganta, James Gibson, Stephen I. Goodman, Cary Harding, Stephen Kahler, David Kronn, Nicola Longo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

3-MCC deficiency is among the most common inborn errors of metabolism identified on expanded newborn screening (1:36,000 births). However, evidence-based guidelines for diagnosis and management of this disorder are lacking. Using the traditional Delphi method, a panel of 15 experts in inborn errors of metabolism was convened to develop consensus-based clinical practice guidelines for the diagnosis and management of 3-MCC screen-positive infants and their mothers. The Oxford Centre for Evidence-based Medicine system was used to grade the literature review and create recommendations graded from A (evidence level of randomized clinical trials) to D (expert opinion). Panelists reviewed the initial evaluation of the screen-positive infant-mother dyad, diagnostic guidelines, and management of diagnosed patients. Grade D consensus recommendations were made in each of these three areas. The panel did not reach consensus on all issues. This consensus protocol is intended to assist clinicians in the diagnosis and management of screen-positive newborns for 3-MCC deficiency and to encourage the development of evidence-based guidelines.

Original languageEnglish (US)
Pages (from-to)363-370
Number of pages8
JournalMolecular Genetics and Metabolism
Volume93
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

methylcrotonoyl-CoA carboxylase
Clinical Protocols
Consensus
Inborn Errors Metabolism
Guidelines
Metabolism
Mothers
Newborn Infant
Evidence-Based Medicine
Practice Management
Expert Testimony
Practice Guidelines
Medicine
Screening
Randomized Controlled Trials
Parturition
3-methylcrotonyl CoA carboxylase 1 deficiency

Keywords

  • 3-Methyl-crotonyl CoA carboxylase deficiency
  • Biotin
  • Carnitine
  • Clinical practice guideline
  • Consensus
  • Delphi
  • Diagnosis
  • Glycine
  • Leucine
  • Management

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. / Arnold, Georgianne L.; Koeberl, Dwight D.; Matern, Dietrich; Barshop, Bruce; Braverman, Nancy; Burton, Barbara; Cederbaum, Stephen; Fiegenbaum, Annette; Garganta, Cheryl; Gibson, James; Goodman, Stephen I.; Harding, Cary; Kahler, Stephen; Kronn, David; Longo, Nicola.

In: Molecular Genetics and Metabolism, Vol. 93, No. 4, 04.2008, p. 363-370.

Research output: Contribution to journalArticle

Arnold, GL, Koeberl, DD, Matern, D, Barshop, B, Braverman, N, Burton, B, Cederbaum, S, Fiegenbaum, A, Garganta, C, Gibson, J, Goodman, SI, Harding, C, Kahler, S, Kronn, D & Longo, N 2008, 'A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency', Molecular Genetics and Metabolism, vol. 93, no. 4, pp. 363-370. https://doi.org/10.1016/j.ymgme.2007.11.002
Arnold, Georgianne L. ; Koeberl, Dwight D. ; Matern, Dietrich ; Barshop, Bruce ; Braverman, Nancy ; Burton, Barbara ; Cederbaum, Stephen ; Fiegenbaum, Annette ; Garganta, Cheryl ; Gibson, James ; Goodman, Stephen I. ; Harding, Cary ; Kahler, Stephen ; Kronn, David ; Longo, Nicola. / A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. In: Molecular Genetics and Metabolism. 2008 ; Vol. 93, No. 4. pp. 363-370.
@article{a22ba07f50c0459c80af26b9dd1809f1,
title = "A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency",
abstract = "3-MCC deficiency is among the most common inborn errors of metabolism identified on expanded newborn screening (1:36,000 births). However, evidence-based guidelines for diagnosis and management of this disorder are lacking. Using the traditional Delphi method, a panel of 15 experts in inborn errors of metabolism was convened to develop consensus-based clinical practice guidelines for the diagnosis and management of 3-MCC screen-positive infants and their mothers. The Oxford Centre for Evidence-based Medicine system was used to grade the literature review and create recommendations graded from A (evidence level of randomized clinical trials) to D (expert opinion). Panelists reviewed the initial evaluation of the screen-positive infant-mother dyad, diagnostic guidelines, and management of diagnosed patients. Grade D consensus recommendations were made in each of these three areas. The panel did not reach consensus on all issues. This consensus protocol is intended to assist clinicians in the diagnosis and management of screen-positive newborns for 3-MCC deficiency and to encourage the development of evidence-based guidelines.",
keywords = "3-Methyl-crotonyl CoA carboxylase deficiency, Biotin, Carnitine, Clinical practice guideline, Consensus, Delphi, Diagnosis, Glycine, Leucine, Management",
author = "Arnold, {Georgianne L.} and Koeberl, {Dwight D.} and Dietrich Matern and Bruce Barshop and Nancy Braverman and Barbara Burton and Stephen Cederbaum and Annette Fiegenbaum and Cheryl Garganta and James Gibson and Goodman, {Stephen I.} and Cary Harding and Stephen Kahler and David Kronn and Nicola Longo",
year = "2008",
month = "4",
doi = "10.1016/j.ymgme.2007.11.002",
language = "English (US)",
volume = "93",
pages = "363--370",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency

AU - Arnold, Georgianne L.

AU - Koeberl, Dwight D.

AU - Matern, Dietrich

AU - Barshop, Bruce

AU - Braverman, Nancy

AU - Burton, Barbara

AU - Cederbaum, Stephen

AU - Fiegenbaum, Annette

AU - Garganta, Cheryl

AU - Gibson, James

AU - Goodman, Stephen I.

AU - Harding, Cary

AU - Kahler, Stephen

AU - Kronn, David

AU - Longo, Nicola

PY - 2008/4

Y1 - 2008/4

N2 - 3-MCC deficiency is among the most common inborn errors of metabolism identified on expanded newborn screening (1:36,000 births). However, evidence-based guidelines for diagnosis and management of this disorder are lacking. Using the traditional Delphi method, a panel of 15 experts in inborn errors of metabolism was convened to develop consensus-based clinical practice guidelines for the diagnosis and management of 3-MCC screen-positive infants and their mothers. The Oxford Centre for Evidence-based Medicine system was used to grade the literature review and create recommendations graded from A (evidence level of randomized clinical trials) to D (expert opinion). Panelists reviewed the initial evaluation of the screen-positive infant-mother dyad, diagnostic guidelines, and management of diagnosed patients. Grade D consensus recommendations were made in each of these three areas. The panel did not reach consensus on all issues. This consensus protocol is intended to assist clinicians in the diagnosis and management of screen-positive newborns for 3-MCC deficiency and to encourage the development of evidence-based guidelines.

AB - 3-MCC deficiency is among the most common inborn errors of metabolism identified on expanded newborn screening (1:36,000 births). However, evidence-based guidelines for diagnosis and management of this disorder are lacking. Using the traditional Delphi method, a panel of 15 experts in inborn errors of metabolism was convened to develop consensus-based clinical practice guidelines for the diagnosis and management of 3-MCC screen-positive infants and their mothers. The Oxford Centre for Evidence-based Medicine system was used to grade the literature review and create recommendations graded from A (evidence level of randomized clinical trials) to D (expert opinion). Panelists reviewed the initial evaluation of the screen-positive infant-mother dyad, diagnostic guidelines, and management of diagnosed patients. Grade D consensus recommendations were made in each of these three areas. The panel did not reach consensus on all issues. This consensus protocol is intended to assist clinicians in the diagnosis and management of screen-positive newborns for 3-MCC deficiency and to encourage the development of evidence-based guidelines.

KW - 3-Methyl-crotonyl CoA carboxylase deficiency

KW - Biotin

KW - Carnitine

KW - Clinical practice guideline

KW - Consensus

KW - Delphi

KW - Diagnosis

KW - Glycine

KW - Leucine

KW - Management

UR - http://www.scopus.com/inward/record.url?scp=40849118431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849118431&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2007.11.002

DO - 10.1016/j.ymgme.2007.11.002

M3 - Article

C2 - 18155630

AN - SCOPUS:40849118431

VL - 93

SP - 363

EP - 370

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -